Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MYGN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
MYGN stock price ended at $3.89 on Friday, after losing-3.47%
The Myriad Genetics Inc stock price decreased by -3.47% on the last trading day (09 May 2025), dropping from 4.09 to 3.89. Throughout the last trading session, the stock experienced a fluctuation of 9.59% , ranging from a day low of $3.86 to a day high of 4.23. The price has declined in 6 of the last 10 days, resulting in a total change of -47.57% during this period. On the last day, trading volume increase by -3.44M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.87M shares were traded, amounting to approximately 15.36M.
MYGN Technical Signals
MYGN(Myriad Genetics Inc Corp) has 6 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-05-06. The total price change during this trend is -46.49%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of MYGN over the last 5 trading days is 26.35M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
MYGN Moving Average Analysis
Myriad Genetics Inc's overall moving average trend leans more bearish as of Sunday, May 11, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $8.463099999999999, and $9.972. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $3.5808999999999997, and $2.0719999999999996. A break-down below any of these levels will issue sell signals.
MYGN Short Selling Analysis
The short sale ratio of Myriad Genetics Inc(MYGN) as of 09 May 2025 is 15.55%, rising from last trading day. With increasing price from 4.03 to 3.89. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Buy
Sell
3
Buy
6
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
6 Bullish Signals
6 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Relative Strength Index (14 days)
RSI_14 < 30
17.241
Bullish
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
0.945
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-246.09
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
-0
Bullish
Williams %R (14 days)
WILLR_14 < -80
-99.256
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
23.35
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-2.134
Bearish
Momentum (10 days)
MOM_10 < 0
-3.53
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-1.044
Bearish
MYGN Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Myriad Genetics Inc(MYGN), our algorithm predicts MYGN's 1-month price at $6.39, with an -15.54%downwardshift. Using a similarity score up to 98.56%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Myriad Genetics Inc (MYGN.O) stock, as of Sunday, May 4, 2025 , forecasts a -15.54% change over the next month, based on its high correlation with MHUA.O stock patterns. The similarity between their price movements over the analyzed periods is 98.56%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
MYGN
Future prediction
Up: -15.54%
MHUA
Down: -15.54%Similarity: 98.56%
Name
Similarity
Up/Down
MHUA.O
98.56%
-15.54%
PRLD.O
98.43%
+27.62%
PRA.N
98.41%
+4.47%
SBLK.O
98.28%
-39.44%
HSII.O
98.26%
+17.46%
SMC.N
98.25%
+3.65%
E.N
98.13%
+4.01%
SBFM.O
98.08%
-14.18%
HOWL.O
98.07%
+11.41%
AIRI.A
98.05%
+18.72%
MYGN Seasonality Analysis
Based on MYGN's historical stock price data across all years, the probability of a positive return in May is45.45%, suggesting it maynotbe an ideal month to invest in MYGN. In contrast,Julyoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Myriad Genetics Inc (MYGN.O) stock in July has the highest probability of a positive return (80.00%), while April has the lowest probability (9.09%).
Performance Seasonality
The chart shows Myriad Genetics Inc. (MYGN)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MYGN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Myriad Genetics Inc (MYGN.O) stock in a year?
The radar chart shows that buying Myriad Genetics Inc (MYGN.O) stock in July has the highest probability of a positive return (80.00%), while April has the lowest probability (9.09%).
How has Myriad Genetics Inc. (MYGN)'s stock price performed over the past three years?
MYGN's stock price rose by 25.43% in 2023,decreased by -27.84% in 2024, and went down by 71.19% in 2025.
Is MYGN a buy based on overall technical signals summary?
MYGN has 6 buy signals and 3 sell signals now. Overall the technical rating for MYGN is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of MYGN.
What is the trend of Myriad Genetics Inc (MYGN)'s moving average?
Myriad Genetics Inc's overall moving average trend leans more bearish as of May 11 2025, with 4 negative signals and 0 positive signal.
What is price prediction for MYGN stock next month?
The price prediction chart for Myriad Genetics Inc (MYGN.O) stock, as of May 04 2025, forecasts a -15.54% change over the next month, based on its high correlation with MHUA stock patterns. The similarity between their price movements over the analyzed periods is 98.56%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for MYGN Stock?
MYGN stock is predicted to reach **$9.00** in 2025, driven by mixed analyst sentiment and technical indicators showing consolidation. The stock faces short-term challenges due to a 13.1% pre-market drop and mixed technical signals, but long-term targets suggest upside potential to **$16.37** based on analyst consensus.
What is price prediction 2030 for MYGN Stock?
MYGN stock is predicted to reach **$15 by 2030**, driven by its focus on molecular diagnostics and precision medicine. Analysts expect growth despite current challenges, with an average target of $16.5 and a high of $29. The stock's technical indicators and improving financials support this outlook.